REVIEW
Halitosis: the multidisciplinary approach
Curd ML Bollen and Thomas Beikler
Halitosis, bad breath or oral malodour are all synonyms for the same pathology. Halitosis has a large social and economic impact. For the majority of patients suffering from bad breath, it causes embarrassment and affects their social communication and life. Moreover, halitosis can be indicative of underlying diseases. Only a limited number of scientific publications were presented in this field until 1995. Ever since, a large amount of research is published, often with lack of evidence. In general, intraoral conditions, like insufficient dental hygiene, periodontitis or tongue coating are considered to be the most important cause (85%) for halitosis. Therefore, dentists and periodontologists are the first-line professionals to be confronted with this problem. They should be well aware of the origin, the detection and especially of the treatment of this pathology. In addition, ear–nose–throat-associated (10%) or gastrointestinal/
endocrinological (5%) disorders may contribute to the problem. In the case of halitophobia, psychiatrical or psychological problems may be present. Bad breath needs a multidisciplinary team approach: dentists, periodontologists, specialists in family medicine, ear–
nose–throat surgeons, internal medicine and psychiatry need to be updated in this field, which still is surrounded by a large taboo.
Multidisciplinary bad breath clinics offer the best environment to examine and treat this pathology that affects around 25% of the whole population. This article describes the origin, detection and treatment of halitosis, regarded from the different etiological origins.
International Journal of Oral Science (2012) 4, 55–63; doi:10.1038/ijos.2012.39; published online 22 June 2012 Keywords: halitosis; microbiology; periodontology
EPIDEMIOLOGY
The amount of epidemiological research on bad breath is limited, since this topic is still a large but underestimated taboo. A public investigation in 2005 in The Netherlands showed that halitosis was one of the 100 biggest human overall exasperations (TNS-NIPO).
There are several reasons for this lack of scientific data. First, there is the difference in cultural and racial appreciation of odours, as for patients as well as for investigators.1Second, there is absence of uni- formity in evaluation methods, as for organoleptical as for mechanical measurements.
A cross-sectional Brazilian study among university students and their families, showed a malodour incidence of 15%. Men suffered more from the problem than women, especially when they were over 20 years.2Japanese researchers investigated 33 000 adults. Fifteen per cent of them declared to suffer from bad breath, with a peak of more than 20% in the city of Tokyo.3Moreover, 70% of the businessmen in Tokyo detected regularly a personal halitosis. In China, more than 25% of a population of 2 000 individuals seems to be suffering from halitosis.4Al-Ansari et al.5showed also in 2006 the same incidence in a Kuwaiti population of 1 500 people. In general, nearly of 25% of the population seems to suffer from bad breath on a regular basis.
Man and women seem to suffer in the same proportions, whereas women seem to seek faster for professional help than men.6Miyazaki found that there is a clear correlation between age and oral malodour:
the older one gets, the more intense the odour will become.7In the United States, Loesche et al.8found that 43% of people over 60 had breath problems. Whereas in the same Group of Turkish individuals,
the incidence seemed to be around 28%.9Bornstein et al.10found nearly the same incidence in Swiss city of Bern. These results suggest that this oral malodour is caused by tongue coating in the younger gene- ration and by periodontitis with tongue coating in the older cohorts.
This large variety of data suggest that there are large shortcomings in the methodology of the overall research projects.11A standardized evaluation protocol for halitosis studies is needed to compare epide- miological data. Therefore, a mechanical detection method should be used as golden standard for bad breath research.
ORIGIN
Microbial degradation in the oral cavity is the main cause of oral malodour. Due to this process, volatile sulphur compounds (VSCs) are formed. The most important VSCs involved in halitosis are hydrogen sulphide (H2S), methyl mercaptan (CH3SH) and dimethyl sulphide (CH3)2S. These VSCs are mainly produced by Gram-negative anaerobic oral bacteria.12Other molecules involved in this bacterial degradation process are: diamines (indole and skatole) or polyamines (cadverin and putrescin). They seem play a less important role in the expression of bad breath.
Most of these components are produced in the proteolytic degra- dation process of peptides. The most predominant substrates in this VSC production are cysteine, cystine and methionine.13The main substrate for skatole and indole production is tryptophan, whereas lysine and ornithine are the basis for the putrescin/cadaverin produc- tion. The involved bacteria in these metabolic processes are shown in Table 1.
Poliklinik fu¨r Zahnerhaltung, Parodontologie und Endodontologie, Westdeutsche Kieferklinik, Universita¨tsklinikum, Du¨sseldorf, Germany
Correspondence: Dr CML Bollen, Poliklinik fu¨r Zahnerhaltung, Parodontologie und Endodontologie, Department of Periodontology, Moorenstrabe 5, Du¨sseldorf 40225, Germany E-mail: curd.bollen@med.uni-duesseldorf.de
Received 12 September 2011; accepted 16 March 2012
Most of the responsible microorganisms in halitosis are involved in periodontitis. So, there is a positive correlation between bad breath and periodontitis: the depth of the periodontal pockets is positively correlated to the height of the VSC concentrations in the mouth.14 When tongue coating is taken into account, the correlation is even more significant.15–16Individuals with a healthy periodontium can show halitosis caused by the impaction of food, bacteria, leucocytes and desquamating epithelial cells on the dorsum of their tongue. This surface is large and has a high retention capacity due to the rough and papillary structure. The bacterial composition on the dorsum of the tongue seems to be identical to the subgingival plaque.17Table 2 shows the main volatile molecules contributing to oral malodour.
Oral pathology, microbiology and xerostomia
In nearly 85% of all halitosis cases, the origin is found in the oral cavity.
A clinical evaluation of malodour on 2 000 patients in Belgium, showed that 76% of these patients had oral causes: tongue coating (43%), gingivitis/periodontitis (11%) or a combination of the two (18%).18
Tongue coating. This phenomenon is the most common cause of bad breath.19The dorsum of the tongue, which is irregular and has a surface of 25 cm2is an ideal niche for oral bacteria.20Since desqua- mating epithelial cells and food remnants are available, putrefaction occurs. Hence, the tongue surface seems to be an important reservoir in the recolonisation of tooth surfaces.21Tongue coating is not easy to remove. Daily scraping or brushing of the tongue can help to reduce the substrata for putrefaction, rather than to reduce the bacterial load.
Moreover, tongue cleaning improves taste sensation.22
Morning breath. Due to the reduced saliva production during night, anaerobic putrefaction will increase, causing the typical morning breath. This is a non-pathological form of halitosis. The problem will disappear as soon as oral hygiene measures are taken. Snel et al.23 concluded that gender seems to play an unknown role in this phenomenon: women manifest higher VSC levels than men in the morning. This phenomenon needs to be further investigated to understand its impact.
Odontogenic halitosis. Poor oral hygiene, dental plaque, dental caries, accumulation and putrefaction of food remnants and unclean acrylic dentures (worn at night or not regularly cleaned or with rough surfaces) contribute to bad breath. The latter was recently concluded in a systematic review, stating that, although isolated reports, chemi- cals and brushing appear to be more effective than placebo in the reduction of plaque coverage and microbial counts of anaerobes and aerobes on complete denture bases.24
Gingivitis and periodontitis are the main causes of the problem.25A positive correlation between the depth of the pockets and the concen- tration of the sulphur components has been shown.15Necrotizing gingivitis or periodontitis cause extreme soiled odours. This disease is caused by opportunistic bacterial infections occurring in individuals with stress, malnutrition, insufficient oral hygiene, smoking or sys- temic diseases.26
Xerostomia. Patients with a dry mouth (0.15 mL?min21instead of 0.25–0.50 mL?min21) often show an increased volume of plaque on teeth and tongue.27The lack of salivary flow, leads to the disappearance of the antimicrobial activity of the saliva and the transition from Gram-positive bacteria to Gram-negative species.28 Hyposialy can be caused by diabetes, Sjo¨gren syndrome, stress, depression, medica- tion, mouth breathing and alcohol abuse. Almost 25% of the elderly suffer from a dry mouth.29Research groups of Kleinberg and Koshimune described properly the correlation between the dry mouth and the increase of halitosis.30–31
Moreover, other salivary factors can influence the development of malodour: an increase of the salivary pH by the intake of amino acids, and a change in the oxygen depletion (a reduction stimulates the metabolism of Gram-negative bacteria, responsible for higher VSC production).32–33
A recent study in elderly found the accumulation of bacterial plaque on the tongue, oral dryness, burning mouth, overnight denture Table 1 Bacteria responsible for VSC production
Volatile sulphur compounds Bacteria
H2S from cysteine Peptosteptococcus anaerobius Micros prevotii
Eubacterium limosum Bacteroides spp.
Centipedia periodontii H2S from serum Prevotella intermedia
Prevotella loescheii
Porphyromonas gingivalis (BANA positive) Treponema denticola (BANA positive) Selenomonas artermidis
CH3SH from methionine Fusobacterium nucleatum Fusobacterium periodonticum Eubacterium spp.
Bacteroides spp.
CH3SH from serum Treponema denticola (BANA positive) Porphyromonas gingivalis (BANA positive) Porphyromonas endodontalis
Other Prevotella melaninogenica
Tanerella forsythensis Eikenella corrodens Solobacterium moorei Treponema forsythensis Centipeda periodontii Atopobium parvulum Adapted from Persson et al.120
Table 2 Volatile molecules contributing to oral malodour
Categories Compounds
Volatile sulphur compounds Methyl mercaptan: CH3SH Hydrogen sulphide: H2S Dimethyl sulphide: (CH3)2S
Diamines Putrescine: NH2(CH2)4NH2
Cadaverine: NH2(CH2)5NH2
Butyric acid: CH3CH2CH2COOH Propionic acid: CH3CH2COOH Valeric acid: C5H10O2
Phenyl compounds Indole: C8H7N Skatole: C9H9N Pyridine: C5H5N
Alcohols 1-propoxy-2-propanol
Alkalines 2-methy-propane
Nitrogen-containing compounds Urea: (NH2)2CO Ammonia: NH3 Ketones
Adapted from Goldberg et al.,13Greenman et al.17and Claus et al.121
wear, and lower educational levels to be significantly related to oral malodour.34
Although xerostomia is associated with aging, studies have demon- strated that salivary gland function is well preserved in the healthy geriatric population. Therefore, dry mouth is probably a condition of systemic or extrinsic origin. Saliva seems to undergo chemical changes with aging. As the amount of ptyalin decreases and mucin increases, saliva becomes thick and viscous and presents problems for the elderly.
One of the most prevalent causes of xerostomia is medication (anti- cholinergics, antihistamines and diuretics dry the mucosa). Chronic mouth breathing, radiation therapy, dehydration and autoimmune diseases (as Sjo¨gren’s) can also diminish salivation, as can systemic illness such as diabetes mellitus, nephritis and thyroid dysfunction.
Xerostomia can lead to dysgeusia, glossodynia, sialadenitis, crack- ing and fissuring of the oral mucosa, and halitosis. Dry mouth symptom can be treated with hydration and sialagogues or with arti- ficial saliva substitutes. In patients with Sjo¨gren’s syndrome and in those who have undergone radiation therapy, pilocarpine has been used with good results.35
Other oral causes. Stomatitis, intra-oral neoplasia, exposed tooth pulps (with necrotic content), extraction wounds (with blood cloth or purulent discharges), or crowding of teeth (favouring food entrap- ment) can also be involved.36Moreover, peri-implantitis, peri-coronitis, recurrent oral ulcerations and herpetic gingivitis, are described as origin for bad breath.37
ENT and pulmonary pathology
Maximally 10% of the oral malodour cases originate from the ears, nose and throat (ENT) region, from which 3% finds its origin at the tonsils.38Very seldom the larynx is involved. Therefore, when a clinical investigation is performed, attention should first be paid to the tonsils:
size, structure (invaginations, coating and hyperaemia) and presence of tonsilloliths.39
Oral causes. Acute tonsillitis is the most important ENT origin.
Mostly, infections with streptococci play a role, but also viral infections (e.g. mononucleosis infectiosa) are possible. When acute tonsillitis takes place more than three times a year, a tonsillectomy can be con- sidered.40A Plaut-Vincent angina (caused by Fusobacterium Plaut- Vincenti and Borrelia Vincenti) is another ENT cause for halitosis.41
The presence of tonsilloliths represents a 10-fold increased risk of abnormal VSC levels.42Anaerobic bacteria detected in tonsilloliths belonged to the species of Eubacterium, Fusobacterium, Porphyromonas, Prevotella, Selenomonas and Tanerella, all of which appear to be associated with the production of VSCs.43Tonsilliliths are asympto- matic phenomena and are therefore never a reason for tonsillectomy.
A tonsillectomy is only performed when oral hygiene measures do not result in improvement of the breath.
Nasal causes. Postnasal drip (caused by mucus of the paranasal sinuses) contacting the dorsum of the tongue is largely involved.44 Foreign bodies in the nasal cavity can produce a foul odour as well.
Also a cleft palate can be the origin of bad breath.45Atrophic rhinitis with bacterial surinfection causes malodour too. This can be caused by tumor rescetions, radiotherapy or overuse of decongestives or cocaine.
Sinusitis. Bacterial sinusitis develops mostly out of acute viral sinu- sitis. Streptococcus pneumonia and Haemophilus influenza are the main responsible bacteria. On radiological or computed tomography (CT)
images, fading is perceived. When purulent mucous is produced, a typical odour appears. In 10% of the sinusitis cases, a tooth or several teeth are involved. In these cases, the spotted bacteria are: Peptostre- tococcus spp., Fusobacterium spp., Prevotella spp. and Porphyromonas spp. Since those bacteria are able to produce VSCs, a clear association to halitosis is available. The treatment of dentogenic problems (even- tual with the additional use of antibiotics) decreases the anaerobic pathogens, even as the odour problem. In the case of chronic sinusitis, 50%–70% of the patients complain about oral malodour.46
Pulmonary pathology. bronchiectasis, lung abscesses and other endo- brochial chronic disorders, i.e. necrotizing pulmonic neoplasias may cause an unpleasant odour.47
Gastro-intestinal pathology
The gastro-intestinal tract can only indirectly (haematogenic) influ- ence bad breath. A majority of patients and physicians still abusively believes that halitosis originates from the stomach. The latter is only correct in ,0.5% of the cases.
Oesophagus. Only in specific cases, this is the origin of malodour.
When a Zenker’s diverticulum is present, a chronic unpleasant odour appears.48The incidence of this phenomenon is less than 0.1% and it is only diagnosed in patients over 65 years of age. Also bleeding of the oesophagus can cause a musty odour. When severe regurgitation is determined, halitosis will be present.49Symptomatically, coughing, postnasal drip, pyrosis, irritations and ulcerations of the oesophagus and halitosis will be detected. pH monitoring is used for diagnosis.
When the diagnosis is missed, carcinomatic deterioration can occur.
Stomach. Infections with Helicobacter pylori can cause peptic ulcers.
There is no 100% clear correlation found between these ulcers and halitosis.50–51In vitro studies show significant VSC production by H.
pylori.52More recent research by Lee et al.53confirmed this statement.
Moreover, it is suggested that H. pylori was detected in subjects with periodontitis, suggesting that progression of periodontal pocket and inflammation may favour colonization by this species and that H. pylori infection may be indirectly associated with oral patho- logical halitosis following periodontitis.54 Kinberg et al.55 showed that halitosis has often been reported among the symptoms related to H. pylori infection and gastroesophageal reflux disease. When gastrointestinal pathology was treated, most of the halitosis com- plaints disappeared. The latter suggests that halitosis can have a gastro-intestinal origin. In a recent comparative study among children in Turkey, it was concluded that there was a difference between the rate of H. pylori infections among those with and without halitosis.
Eradication treatment was found beneficial in the treatment of children with halitosis and positive H. pylori stool antigen test. The results, however, were not statistical significant.56
In general, it can be concluded that more research has to be done to clarify a clear correlation between stomach problems by H. pylori infections and halitosis.
Intestines. In cases of intestinal obstruction, a faecal mouth odour may be detectable, as found in two siblings with extrinsic duodenal obstruc- tion caused by congenital peritoneal bands.57Attention was drawn to the unusual physical sign of halitosis as a presenting feature. It was suggested that this physical sign may be an indication for barium studies.
Metabolic disorders
Preti et al.58discussed already in 1992 a number of non-oral causes for oral malodour. Several well-documented aetiologies for non-oral malodour include renal failure, cirrhosis of the liver and diabetes mellitus. In addition, there appeared to be several other metabolic conditions involving enzymatic and transport anomalies (such as tri- methylaminuria) which lead to the systemic production of volatile malodours that manifest themselves as halitosis and/or altered che- moreception.
Renal disease in the form of chronic renal failure is associated with high blood urea nitrogen levels and low salivary flow rates. Peritoneal dialysis decreased the problem.59The dispersed odour is a typical uremic odour in combination with a dry mouth. Also pancreatic insufficiencies can cause oral bad odours as found by Feller and Blignaut in 2005.60
Diabetic ketoacidosis leads to a typical breath odour.61Diabetes type 2 demonstrates a typical sweet and fruity odour.62Due to gas chromatography–mass spectrometry, it seems possible to detect dif- ferent extra-oral causes of halitosis such as diabetes.63
Several metabolic disorders in the bowels, like trimethylaminuria cause a specific fishy odour. According to Whittle et al.,64this genetic disease is the largest cause of undiagnosed body odour. Trimethyl- aminuria is a disorder in which the volatile, fish-smelling compound, trimethylamine accumulates and is excreted in the urine, but it is also found in the sweat and breath. Because many patients have associated body odours or halitosis, trimethylaminuria sufferers can meet serious difficulties in their social context, leading to isolation and even depres- sion. Trimethylamine is formed by bacteria in the mammalian gut from reduction of compounds such as trimethylamine-N-oxide and choline. Primary trimethylaminuria sufferers have an inherited enzyme deficiency where trimethylamine is not efficiently converted to the non-odorous trimethylamine-N-oxide in the liver. Diagnosis of trimethylaminuria requires the measurement of trimethylamine and trimethylamine-N-oxide in urine, which should be collected after a high substrate meal in milder or intermittent cases, a marine- fish meal. The symptoms of trimethylaminuria can be improved by changes in the diet to avoid precursors, in particular trimethylamine- N-oxide which is found in high concentrations in marine fish.
Treatment with antibiotics to control bacteria in the gut, or activated charcoal to sequester trimethylamine, may also be beneficial.65
Recently, an article by Scully and Greenman66 reviewed the aetiopathogenesis of halitosis. They stated that only in a few patients, metabolic anomalies are responsible. If this condition is pre- sent, the extra-oral origin should be determined, because the latter requires medical investigation and support in therapy.
Hepathology and endocrinology
The liver can be involved in oral malodour. Due to a reduced liver function, waste products are eliminated through the lungs, causing the
‘fetor hepticus’: a sweet, excremental odour (the breath of death).
Fetor hepaticus is an expression of hepatic encephalopathy.67Liver failure inhibits the detoxification in the whole body, causing unplea- sant odours.68 Also some hereditary disorders can influence the breath: tyrosinemy is the most important example (cabbage odour).
Endocrinology can also contribute to halitosis. Not only the hor- monal cycle seems to influence the mouth odour, but also a lot of other intestinal diseases.69–70
Recently, van Steenberghe mentioned a whole list of metabolic and endocrinological aspects in correlation to oral malodour.62This list is resumed in Table 3.
Medication
Next to medication resulting in a dry mouth (see above); recently the use of bisphosphonates can contribute to oral malodour. Bisphospho- nate-induced osteonecrosis is since 2003 a common problem.71The product is used systemically in cases of malignant bone tumours and their metastases. Often this results in jawbone necrosis, a clear origin for a filthy odour. The necrotic sequesters should be removed and it is tried to cover up the necrotic area with a steeled flap.72
DETECTION
The gold standard is the organoleptic scoring, i.e., smelling the odour of the patient. A more objective method is the analysis of breath samples by gas chromatography or by means of portable VSC analysers.
Organoleptic scoring
In expired air, more than 150 different components have been detected. The perception of these molecules is dependent of the olfac- tory response, the threshold concentration, the strength of the odour and the volatility of the molecules. When organoleptical scoring is performed, a well-trained clinician determines if the odour samples smells bad or not, giving a score to the intensity. Theses scores go from 0 up to 5 (Table 4).
From every patient, different samples are analysed:
. mouth odour (smelled at 10 cm form the oral cavity: while the patient normally breaths and while the patient counts loudly to 10);
. saliva odour (measured by the wrist-lick test: the patient licks at the wrist, and after 10 s of drying, a score is given to this sample);
. tongue coating (a score is given to debris, scraped from the dorsum of the tongue with a periodontal probe);
Table 3 Odours in the case of metabolic or endocrinological problems Odours Metabolic or endocrinological problems
Fruity odour Type-1-diabetes in children Type-2-diabetes in adults Alcoholic ketoacidosis Faecal odour Intestinal obstruction Ammonia of fishy odour Kidney-insufficiency
Trimethylaminuria
Mouse odour Phenylketonuria
Cooked cabbage odour Methionine adenosyl transferase deficiency Sweating feet odour Isovaleriaan acidity
Deficiency on chromosome 15 Burned sugar odour Maple syrup urine disease Sweet musty odour Homocystinuria Rotten eggs odour Disease of Lignac Adapted from van Steenberge.62
Table 4 Organoleptical scoring scale Rosenberg & McCulloch scale Description
0 No detectable odour
1 Hardly detectable odour
2 Light odour
3 Moderate odour
4 Strong odour
5 Extremely strong odour
Adapted from Rosenberg and McCulloch.75
. interdental ‘floss’ (after flossing with dental tape, the odour of the floss is scored);
. nasal odour (while the patient is breathing through the nose (mouth closed), a score is given to the exhaled air);
. prosthesis odour (if the patient wears a partial or full removable denture, scoring of the odour of this prosthetic is noted).
To gather optimal test results several precautions should be taken before the examinations: the patient should refrain from spicy foods, garlic or onions the day before the examination. At least 12 h before the consultation, teeth should not be cleaned or rinsed, perfumes should be avoided and at least 6 h before the examination, the intake of food or liquids should be avoided. Smoking should be stopped at least 24 h before any examination.73
The advantages of organoleptical scoring are: inexpensive, no equipment needed and a wide range of odours is detectable. As dis- advantages, the extreme subjectivity of the test, the lack of quantifi- cation, the saturation of the nose and the reproducibility can be mentioned.74 Still, organoleptic scoring is considered as the gold standard in the detection of oral bad breath.
Portable gas analysis
The Halimeter (Interscan corporation, Chatsworth, CA, USA) and OralChroma (Abimedical corporation, Miyamae-ku Kawasaki-shi, Kanagawa, Japan) are electronic devices available to detect some of the volatile sulphur components in expired air. The OralChroma is a portable gas chromatograph offering lower cost, higher performance and more user-friendly operations than conventional gas chromato- graphs by limiting the target gases to three types: H2S, CH3SH and (CH3)2S. Also, an interpretation of the results can be shown to the patients.
The Halimeter can only give an idea of the total amount of VSCs, present in a sample. In the Halimeter, the total amount ppb (parts per billion) of VSCs in the sample is marked. In normal situations this value is less than 100 ppb. When 300–400 ppb are detected in the mouth air, a persistent oral odour can be concluded.15,75
These portable machines have a lot of advantages: easy to handle, fast results, portable and reproducible. Furthermore, they are rather inexpensive and can be controlled by untrained staff. As disadvantage, the limited diversity in the explored gasses should be stated. Recently, it was shown that the OralChroma may produce a more comprehen- sive assessment of VSC production by oral microflora than the Halimeter.76It would desirable to select one machine as gold standard to make different studies comparable in the future.
Gas chromatography
In halitosis research, the gas chromatography (GC) analysis can be performed on breath, saliva and tongue debris. Almost all different air components can be detected. In expired air, almost 500 different sub- stances can be demonstrated.77GC in malodour research is still in an experimental stage, although used since the late 1960s.78VSCs can be well detected, but the challenge will be to analyse the other contribu- ting components of oral malodour. Also the associations of different odours with specific systemic disease can and should be investigated.
GC has several advantages: an analysis of almost all components with high sensitivity and specificity. The method is non-invasive, but expensive and a well-trained staff is needed. The progression of the method takes much more time and the machine cannot be used in daily practice.79
Recently, trailblazing research was performed by van den Velde et al.63,68with gas chromatography–mass spectrometry as a tool for
differential diagnosis of halitosis, with the possibility to detect extra- oral causes, which often remain undetected unless characterized by a specific smell.
THERAPY Oral causes
Since the oral causes are related to microorganisms, the therapy can consist of: (i) mechanical reduction of the intra-oral nutrients and micro-organisms; (ii) chemical reduction of microorganisms; (iii) inverting volatile fragrant gasses into non-volatile components or (iv) masking of the malodour.80
Mechanical reduction. Tongue coating is the most prominent factor and therefore, extensive tongue cleaning is of utmost importance. The scraping of the dorsum of the tongue reduces the available nutrients even as the available microorganisms, leading to an improvement of the odour.81Home tongue cleaning can be performed with a regular toothbrush, but a specific tongue scraper is advised. A brush is less aggressive on the soft tissues.82Since the largest amount of coating is found on the dorsal part of the tongue surface, a cleaning as posterior as possible is advised. To prevent from vomiting, it is counselled to pull out the tongue when scraping.
A systemic review by van der Sleen et al.83demonstrated that tongue brushing or tongue scraping have the potential to successfully reduce breath odour and tongue coating. Due to tongue cleaning, the taste seems to improve again.84Interdental cleaning and toothbrushing are also necessary to control plaque and oral microorganisms.
A Cochrane review from 2006, compared randomized controlled trials for different methods of tongue cleaning to reduce mouth odour in adults with halitosis.85Only two trials were included, involving 40 participants. Due to the clinical heterogeneity between these two studies, only a descriptive summary could be made. It is concluded that there is a weak and unreliable evidence to show that there is a small but statistically significant difference in reduction of VSC levels when scrapers or cleaners rather than toothbrushes are used to reduce halitosis in adults. More coherent studies are required to come to clear conclusions.
Since periodontitis is one of the main causes of oral malodour, a professional periodontal therapy should be performed. A one-stage full-mouth disinfection, as described by Bollen et al.,86combining scaling and rootplaning in combination with chlorhexidine, has a significant microbiological improvement up to 2 months and reduces the organoleptical scores, in particular for saliva samples, who seems to be representative for organoleptical scoring.87
When patients’ response to treatments at a multidisciplinary breath odour clinic was considered, it was concluded that education of the public and dental professionals in a more consequent general oral hygiene might elevate the level of compliance and could cause thereby an amelioration of the problem.88
Chemical reduction. Rinsing is a common practice in the approach of oral malodour. The most used rinsing components are:
. chlorhexidine (CHX): CHX is the most efficient molecule against plaque. Rosenberg showed that rinsing with 0.2% CHX causes a reduction of 43% in VSCs and of 50% in the organoleptical scores on a day-long basis.89
. essential oils: these products give only a short-term and restricted effect (25% reduction) for 3 h. Also, the reduction in odour- producing bacteria is limited.90
. chlordioxide: chlordioxide is a strong oxidizing product that can reduce oral malodour by the oxidation of H2S, CH3SH, cysteine and methionine. A reduction of 29% in odour after 4 h was reported.91
. triclosan: triclosan is effective against the majority of oral bacteria.
An 84% reduction of VSCs after 3 h is proved.92
. aminefluoride/tinfluoride: the combination of AmF/SnF2 can cause an 83% reduction in the morning halitosis.84
. H2O2: a concentration of 3% of this product can result in a 90%
VSC reduction after 8 h.93
Toothpastes, containing stannous fluoride, zinc or triclosan, seem to have proved their beneficial effect in reducing the oral malodour for a limited period of time.94–96
In a recent Cochrane review by Fedorowicz, only five randomized controlled trials could be found, involving 293 participants.97In view of the clinical heterogeneity between the trials, pooling of the results and a meta-analysis of the extracted data was not feasible. Compared to placebo, 0.05% chlorhexidine10.05% cetylpyridinium chloride1 0.14% zinc lactate mouthrinse significantly reduced the organoleptic scores, but showed significantly more tongue and tooth staining. It is concluded that this mouthrinse plays an important role in reducing the levels of halitosis producing bacteria on the tongue and can be effective in neutralization of odoriferous sulphur compounds. But well-designed, randomized controlled trials with larger sample size, a longer intervention and follow-up period are still needed to confirm these results.
Transformation of volatile sulphur components. Metal ions with affi- nity for sulphur, pick up sulphur-containing gasses. Zinc, mercury and copper are the most important metals.98 A commercial rinse (containing 0.005% CHX, 0.05% cetylpyridinium chloride (CPC) and 0.14% zinc lactate) seems to be much more efficient than CHX alone, due to the effect of zinc. Zinc plus CHX seem to have a syn- ergistic effect as Young et al.99proved.
Masking effect. Rinsing products, sprays, mint tablets or chewing gum only have a short-term masking effect.100 Mostly, they increase the saliva production, thereby retaining more soluble sulphur compo- nents for a short period of time.30
ENT and pulmonology
When problems in this area are considered, patients should be referred to an ENT specialist or a pulmonologist. Acute pharyngitis can be treated symptomatically, when a viral infection is at stake. A salicylic intake seems efficient when started from the prodromal stage onwards.
Chlorhexidine sprays can prevent bacterial overgrowth and reduce the breath malodour. If pharyngitis is of bacterial origin, group A strep- tococci are mostly responsible. The infection can be confirmed by bacterial culturing or by antigen tests. Treatment with penicillin is imperative to prevent rheumatic fever. The breath malodour will soon disappear.101Foreign objects in the nose should be removed.
Acute infective sinusitis can be treated by an appropriate antimi- crobial. Broad-spectrum penicillin or cephalosporin is the choice.
Sometimes, a surgical widening of the ostia is needed, especially if recurrences are observed. If the problem is of dental origin, this infec- tion should be treated first. Periapical tooth infections, particularly of second molars are mostly responsible. Endodontic treatment or extraction of the tooth is the options.
The treatment of chronic sinusitis is depending on the underlying cause. The problem will be treated by medications containing vaso- constrictors associated or not with H1antihistaminic, rinsing of the sinuses or even surgical removal of the inflamed mucosa and polyps.102 In the case of chronic tonsillitis, the elimination of the deep crypts, which harbour exfoliated cells, debris and bacteria, is important.
Prescribing antibiotics like metronidazole has only a short-term effect. Cryptolysis by means of CO2laser is another option.103Ozena seems to respond well to a prolonged treatment of fluoroquiolone, which are highly effective against Gram-negative bacteria including Heamophilus influenza. Prolonged treatment can produce however some side effects as photosensibilisation or tendinitis.104
In the case of tonsilloliths, a proper hygiene can be instructed by squeezing out the debris out of the cryptic tonsils. This handling requires exercising.
Gastro-intestinology
In the case of regurgitation esophagitis, the treatment mostly consist of weight reduction, prohibition of coffee and tobacco, avoidance of extensive meals in the evening, placing the head of the bed in a slightly higher position. H2anatgonists can be prescribed.105When H. pylori infections are noticed, the therapy consists of the intake of omeprazol, amoxicillin en clarithromycin.106
A Zenker diverticle must be surgically removed. For a stomach hernia, generally a surgical intervention will be necessary.
Hepathology and endocrinology
In severe hepatologic problems, a liver transplantation can be neces- sary. In less life-threatening situations, a liver dialysis can be sufficient to treat the problems. In more simple pathology, cortisone therapy and a stringent diet can be enough.107
In the endocrinological range of problems, the underlying diseases should be treated. The detailed approach of these therapies falls out- side the scope of this article.
Probiotics
Recently several studies were performed to replace bacteria respon- sible for halitosis with probiotics as Streptococcus salivarius (K12), Lactobacillus salivarius or Weissella cibaria. The objective is to prevent re-establishment of non-desirable bacteria and thereby limit the re- occurrence of oral malodour over a prolonged period. Several studies conclude that probiotic bacterial strains, originally sourced from the indigenous oral microbiotas of healthy humans, may have potential application as adjuncts for the prevention and treatment of hali- tosis.108The oral administration of the probiotic lactobacilli not only seemed to improve the physiologic halitosis, but also showed bene- ficial effects on bleeding on probing from the periodontal pockets.109 Moreover, Weisella cibaria isolates possess the ability to inhibit VSC production under both in vitro and in vivo conditions, demonstrating that they bear the potential for development into novel probiotics for use in the oral cavity.110 Gut-caused halitosis, although rarely occurring, can be successfully treated with a suspension of living non-pathogenic Escherichia coli bacteria.111 Scully and Greenman66 showed that emergent halitosis treatments include probiotics and vaccines targeted against causal microorganisms or their products.
PSYCHOLOGICAL ASPECTS
In general, humans cannot detect their own bad breath. Therefore, it is unusual that patients can detect their halitosis, although there is nothing wrong. This kind of patients often frequents a halitosis clinic.
Halitophobia
This is the fear of having bad breath that other people find offensive.
Moreover, 0.5%–1% of the adult population is affected with this problem in their social live. These patients consider having bad breath, do not have it, but get not convinced during diagnosis and therapy.
Non-real halitosis or halitophobia is understood by the compulsive idea to suffer from bad breath and to irritate others by this.
Nagel mentions that consultation hours for halitosis should be prepared for patients with non-real halitosis and build up correspond- ing interdisciplinary contacts.112The ‘treatment’ of these patients is impossible, since they are not into the arguments stated by a physician.
Mostly, these patients hop from clinic/specialist to clinic/specialist to find an argument for their self-esteemed problem. Imagined halitosis is poorly documented in the psychiatric literature.113 Many of the cases with imagined halitosis described in the literature resemble the psychiatric syndrome of social phobia.114
Olfactory reference syndrome
Olfactory reference syndrome (ORS) is defined as the psychiatric con- dition characterized by persistent preoccupation about body odour accompanied by shame, embarrassment, significant distress, avoid- ance behaviour and social isolation.115ORS has, however, not been included in the Diagnostic and Statistical Manual of Mental Disorders and, given that it is primary symptoms may be found in various other disorders, differential diagnosis can be problematic. ORS seems to represent a unique cluster of symptoms that can be delineated as a separate diagnostic entity, and ORS falls on a spectrum of social anxiety disorders that includes social anxiety disorder, taijin kyofusho and body dysmorphic disorder.116
Pseudo-halitosis
These are patients who consider to have bad breath, but who does not have it, and finally get convinced during diagnosis and therapy.
Seemann describes data collected from a multidisciplinary breath consultation in Germany.73According to this research, 28% of these patients complaining of bad breath did not show signs of bad breath—
meaning that their concern of halitosis was exaggerated. Within this group, 76% received prior treatments for bad breath, 36% received gastroscopies and 14% underwent an ENT operation—all without having detectable signs of bad breath. Only 9% of these patients went through an organoleptic evaluation before they underwent these medical procedures. Patients with pseudo-halitosis show more often symptoms of depression.117
Therapy
Selective Serotonin Reuptake Inhibitor, which increases the concen- tration of serotonin in the brain, can help to treat this phenomenon.118 When tricyclic antidepressant medication is used, xerostomia can appear, leading to an increase of halitosis awareness.119Patients with symptoms of halitophobia or ORS, should not be treated by dental practitioners or by ENT specialists, but should be referred to psycho- logists or even to psychiatrists.
CONCLUDING REMARKS
Halitosis is a common condition, affecting around 25% of the general population. The origin of the problem largely arises from intra-oral causes, whereas only a limited number of cases are the result of extra oral or systemic problems. Nevertheless, proper investigation and management of these extra oral causes is important for the total under- standing of this phenomenon. Halitosis from an extra-oral origin can
be the sign of an underlying systemic disease. Therefore, it is substan- tiated to organize halitosis consultations in a multidisciplinary setting, assembling periodontologists, ENT specialists, specialists in internal medicine and psychologists or even psychiatrists.
Although oral malodour is mostly associated with poor oral hygiene and the presence of gingivitis or even periodontitis, evidence suggests that anaerobic microorganisms present in the tongue coating, are the overwhelming cause of this condition. A limited number of successful treatment regimens have been described, but more research on the long-term outcomes of these therapies will be required. Also new and more long lasting in-office treatments should be developed and tested.
1 Rayman S, Almas K. Halitosis among racially diverse populations: an update. Int J Dent Hyg 2008; 6(1): 2–7.
2 Nadanovsky P, Carvalho LB, Ponce de Leon A. Oral malodour and its association with age and sex in a general population in Brazil. Oral Dis 2007; 13(1): 105–109.
3 Saito H, Kawaguchi Y. Halitosis prevention campaign: a report of oral health promotion activities in Japan. Int Dent J 2002; 52(Suppl 3): 197–200.
4 Liu XN, Shinada K, Chen XC et al. Oral malodour-related parameters in the Chinese general population. J Clin Periodontol 2006; 33(1): 27–31.
5 Al-Ansari JM, Boodai H, Al-Sumait N et al. Factors associated with the self-reported halitosis in Kuwaiti patients. J Dent 2006; 34(7): 444–449.
6 Rosenberg M, Kulkarni GV, Bosy A et al. Reproducibility and sensitivity of oral malodour measurements with a portable sulphide monitor. J Dent Res 1991;
70(11): 436–440.
7 Miyazaki H, Sakao S, Katoh Y et al. Correlation between volatile sulphur compounds and certain oral health measurements in the general population. J Periodontol 1995;
66(8): 679–684.
8 Loesche WJ, Grossman N, Dominguez L et al. Oral malodour in the elderly. In: van Steenberghe D, Rosenberg M, editors. Bad breath: A multi-disciplinary approach.
Leuven: Leuven University Press, 1996: 181–194.
9 Avcu N, Ozbek M, Kutoglu D et al. Oral findings and health status among hospitalized patients with physical disabilities, aged 60 or above. Arch Gerontol Geriatr 2005;
41(1): 69–79.
10 Bornstein MM, Kislig K, Hoti BB et al. Prevalence of halitosis in the population of the city of Bern, Switzerland: a study comparing self-reported and clinical data. Eur J Oral Sci 2009; 117(3): 261–267.
11 Vandekerckhove B, Bollen C. Epidemiology in the general population, specific populations and in a multidisciplinary halitosis consultation. In: van Steenberghe D, editor. Ademgeur. Houten: Prelum Uitgevers, 2009: 3–10.
12 Krespi YP, Shrime MG, Kacker A. The relationship between oral malodour and volatile sulphur compound producing bacteria. Otolaryngol Head Neck Surg 2006; 135(5):
671–676.
13 Goldberg S, Kozlovsky A, Gordon D et al. Cadaverine as a putative component of oral malodour. J Dent Res 1994; 73(6): 116821172.
14 Calil C, Liberato FL, Pereira AC et al. The relationship between volatile sulphur compounds, tongue coating and periodontal disease. Int J Dent Hyg 2009; 7(4):
251–255.
15 Yaegaki K, Sanada K. Volatile sulphur-compounds in mouth air from clinically healthy subjects and patients with periodontal disease. J Periodont Res 1992; 27(4 Pt 1):
233–238.
16 Tanaka M, Yamamoto Y, Kuboniwa M et al. Contribution of periodontal pathogens on tongue dorsa analysed with real-time PCR to oral malodour. Microbes Infect 2004;
6(12): 1078–1083.
17 Greenman J, Duffield J, Spencer P et al. Study on the organoleptic intensity scale for measuring oral malodour. J Dent Res 2004; 83(1): 81285.
18 Quirynen M, Dadamio J, van den Velde S et al. Characteristics of 2000 patients who visited a halitosis clinic. J Clin Periodontol 2009; 36(11): 970–975.
19 Rolda´n S, Herrera D, Sanz M. Biofilms and the tongue: therapeutical approaches for the control of halitosis. Clin Oral Investig 2003; 7(4): 189–197.
20 Collins LM, Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res 1987; 66(8): 1300–
1302.
21 Faveri M, Feres M, Shibli JA et al. Microbiota of the dorsum of the tongue after plaque accumulation: an experimental study in humans. J Periodontol 2006; 77(9): 1539–
1546.
22 Quirynen M, Avontroodt P, Soers C et al. Impact of tongue cleansers on microbial load and taste. J Clin Periodontol 2004; 31(7): 506–510.
23 Snel J, Burgering M, Smit B et al. Volatile sulphur compounds in morning breath of human volunteers. Arch Oral Biol 2011; 56(1): 29–34.
24 de Suza RF, de Freitas Oliveira Paranhos H, Lovato da Silva CH et al. Interventions for cleaning dentures in adults. Cochrane Database Syst Re 2009; (4): CD007395.
25 Morita M, Wang HL. Association between oral malodour and adult periodontitis: a review. J Clin Periodontol 2001; 28(9): 813–819.
26 Horning GM. Necrotizing gingivostomatitis: NUG to noma. Compend Contin Educ Dent 1996; 17(10): 951–958.
27 Albuquerque DF, de Souza Tolentino E, Amado FM et al. Evaluation of halitosis and sialometry in patients submitted to head and neck radiotherapy. Med Oral Pathol Oral Cir Bucal 2010; 15(6): e850–e854.
28 Almsta˚hl A, Wikstro¨m M. Oral microflora in subjects with reduced salivary secretion.
J Dent Res 1999; 78(8): 1410–1416.
29 Pajukoski H, Meurman JH, Halonen P et al. Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92(6): 641–649.
30 Kleinberg I, Wolff MS, Codipilly DM. Role of saliva in oral dryness, oral feel and oral malodour. Int Dent J 2002; 52(Suppl 3): 236–240.
31 Koshimune S, Awano S, Gohara K et al. Low salivary flow and volatile sulphur compounds in mouth air. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;
9(1): 38–41.
32 Iwanicka-Grzegorek K, Lipkowska E, Kepa J et al. Comparison of ninhydrin method of detecting amine compounds with other methods of halitosis detection. Oral Dis 2005;
11(Suppl 1): 37–39.
33 Traudt M, Kleinberg I. Stoichiometry of oxygen consumption and sugar, organic acid and amino acid utilization in salivary sediment and pure cultures of oral bacteria. Arch Oral Biol 1996; 41(10): 965–978.
34 Nalcaci R, Baran I. Oral malodor and removable complete dentures in the elderly. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105(6): e5–e9.
35 Astor FC, Hanft KL, Ciocon JO. Xerostomia: a prevalent condition in the elderly. Ear Nose Throat J 1999; 78(7): 476–479.
36 Prahabita PK, Bhat KM, Bhat GS. Oral malodor: a review of the literature. J Dent Hyg 2006; 80(3): 8.
37 Delanghe G, Ghyselen J, van Steenberghe D et al. Multidisciplinary breath-odour clinic. Lancet 1997; 350(9072): 187.
38 van den Broek AM, Feenstra L, de Baat C. A review of the current literature on aetiology and measurement methods of halitosis. J Dent 2007; 35(8): 627–635.
39 Ansai T, Takehara T. Tonsilloliths as a halitosis-inducing factor. Br Dent J 2005;
198(5): 263–264.
40 Mulwafu W, Fagan JJ, Isaacs S. Adult tonsillectomy—are long waiting lists putting patients at risk? S Afr J Surg 2006; 44(2): 66–68.
41 Attia EL, Marshall KG. Halitosis. Can Med Assoc J 1982; 126(11): 1281–1285.
42 Fletcher SM, Blair PA. Chronic halitosis from tonsilloliths: a common aetiology. J La State Med Soc 1988; 140(6): 7–9.
43 Tsuneishi M, Yamamoto T, Kokegucji S et al. Composition of the bacterial flora in tonsilloliths. Microbes Infect 2006; 8(9/10): 2384–2389.
44 Amir E, Shimonov R, Rosenberg M. Halitosis in children. J Pediatr 1999; 134(4):
338–343.
45 Monteiro-Amado F, Chinellato LE, de Rezende ML. Evaluation of oral and nasal halitosis parameters in patients with repaired cleft lip and/or palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100(6): 682–687.
46 Lanza DC. Diagnosis of chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2004;
193(Suppl 1): 10–14.
47 Mazzone PJ. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol 2008; 3(7): 774–780.
48 Stoeckli SJ, Schmid S. Endoscopic stapler-assisted diverticuloesophagostomy for Zenker’s diverticulum: patient satisfaction and subjective relief of symptoms.
Surgery 2002; 131(2): 158–162.
49 Struch F, Schwahn C, Wallaschofski H et al. Self-reported halitosis and gastro- oesophageal reflux disease in the general population. J Gen Intern Med 2008;
23(3): 260–266.
50 Werdmuller BF, van der Putten TB, Balk TG et al. Clinical presentation of Helicobacter pylori-positive and -negative functional dyspepsia. J Gastroenterol Hepatol 2000;
15(5): 498–502.
51 Moshkowitz M, Horowitz N, Leshno M et al. Halitosis and gastroesophageal reflux disease: a possible association. Oral Dis 2007; 13(6): 581–585.
52 Hoshi K, Yamano Y, Mitsunaga A et al. Gastrointestinal diseases and halitosis:
association of gastric Helicobacter pylori infection. Int Dent J 2002; 52(Suppl 3):
207–211.
53 Lee H, Kho HS, Chung JW et al. Volatile sulphur compounds produced by Helicobacter pylori. J Clin Gastroenterol 2006; 40(5): 421–426.
54 Suzuki N, Yoneda M, Naito T et al. Detection of Helicobacter pylori DNA in the saliva of patients complaining of halitosis. J Med Microbiol 2008; 57(Pt 12): 1553–1559.
55 Kinberg S, Stein M, Zion N et al. The gastrointestinal aspects of halitosis. Can J Gastroenterol 2010; 24(9): 552–556.
56 Yilmaz AE, Bilici M, Tonbul A et al. Paediatric halitosis and Helicobacter pylori infection. J Coll Physicians Surg Pak 2012; 22(1): 27–30.
57 Stephenson BM, Rees BI. Extrinsic duodenal obstruction and halitosis. Postgrad Med J 1990; 66(777): 568–570.
58 Preti G, Clark L, Cowart BJ et al. Non-oral aetiologies of oral malodour and altered chemosensation. J Periodontol 1992; 63(9): 790–796.
59 Keles M, Tozoglu U, Uyanik A et al. Does peritoneal dialysis affect halitosis in patients with end-stage renal disease? Perit Dial Int 2011; 31(2): 168–172.
60 Feller L, Blignaut E. Halitosis: a review. J South African Den Assoc 2005; 60(1): 17–
19.
61 Bollen CM, Rompen EH, Demanez JP. Halitosis: a multidisciplinary problem. Rev Med Liege 1999; 54(1): 32–36. French.
62 van Steenberge D. Endocrinological aspects. In: van Steenberghe D, editor.
Ademgeur. Houten: Prelum Uitgevers, 2009: 107–115.
63 van den Velde S, Quirynen M, van Hee P et al. Halitosis associated volatiles in breath of healthy subjects. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 853(1/2):
54–61.
64 Whittle CL, Fakharzadeh S, Eades J et al. Human breath doors and their use in diagnosis. Ann N Y Acad Sci 2007; 1098: 252–266.
65 Mackay RJ, McEntyre CJ, Henderson C et al. Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin Biochem Rev 2011; 32(1): 33–43.
66 Scully C, Greenman J. Halitology (breath odour: aetiopathogenesis and management).
Oral Dis 2012; 18(4): 333–345.
67 Tangerman A, Meuwese-Arends MT, Jansen JB. Foetor hepaticus. Lancet 1994;
343(8912): 1569.
68 van den Velde S, Nevens F, van Hee P et al. GC-MS analysis of breath odor compounds in liver patients. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 875(2): 344–
348.
69 Kawamoto A, Sugano N, Motohashi M et al. Relationship between oral malodour and the menstrual cycle. J Periodontal Res 2010; 45(5): 681–687.
70 Calil CM, Lima PO, Bernardes CF et al. Influence of gender and menstrual cycle on volatile sulphur compounds production. Arch Oral Biol 2008; 53(12): 1107–1112.
71 Marx RE. Pamidronate (Aridea) and zoledronateinduced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61(9): 1115–1118.
72 Stockmann P, Vairaktaris E, Wehrhan F et al. Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer 2010; 18(4): 449–460.
73 Seemann R. Organoleptische Beurteilung. In: Seemann R, editor. Halitosis- management in der Zahna¨rztlichen praxis. Balingen: Spitta, 2006.
74 Tonzetich J. Production and origin of oral malodour: a review of mechanisms and methods of analysis. J Periodontol 1977; 48(1): 13–20.
75 Rosenberg M, McCulloch CA. Measurement of oral malodour: current methods and future prospects. J Periodontol 1992; 63(9): 776–782.
76 Salako NO, Philip L. Comparison of the use of the Halimeter and the OralChroma2in the assessment of the ability of common cultivable oral anaerobic bacteria to produce malodorous volatile sulphur compounds from cysteine and methionine. Med Princ Pract 2011; 20(1): 75–79.
77 Tonzetich J. Direct gas chromatographic analysis of sulphur compounds in mouth air in man. Arch Oral Biol 1971; 16(6): 587–597.
78 Larsson BT, Widmark G. A gas chromatographic method for analysis of volatiles in saliva samples. Acta Pharm Sued 1969; 6(4): 479–488.
79 Tonzetich J, Coil JM, Ng W. Gas chromatographic method for trapping and detection of volatile organic compounds from human mouth air. J Clin Dent 1991; 2(3): 79–82.
80 Bradshaw DJ, Perring KD, Cawkill PM et al. Creation of oral care flavours to deliver breath-freshening benefits. Oral Dis 2005; 11(Suppl 1): 75–79.
81 Menon MV, Coykendall AL. Effect of tongue scraping. J Dent Res 1994; 73(9): 1492.
82 Outhouse TL. A platinum standard of effectiveness in oral health care interventions:
the Cochrane systemic review. Gen Dent 2006; 54(4): 228–229.
83 van der Sleen MI, Slot DE, van Trijffel E et al. Effectiveness of mechanical tongue cleaning on breath odour and tongue coating: a systematic review. Int J Dent Hyg 2010; 8(4): 258–268.
84 Quirynen M, Zhao H, van Steenberghe D. Review of the treatment strategies for oral malodour. Clin Oral Investig 2002; 6(1): 1–10.
85 Outhouse TL, Al-Alawi R, Fedorowicz Z et al. Tongue scraping for treating halitosis.
Cochrane Database Syst Rev 2006; (2): CD005519.
86 Bollen CM, Vandekerckhove BN, Papaioannou W et al. Full- versus partial-mouth disinfection in the treatment of periodontal infections. A pilot study: long-term microbiological observations. J Clin Periodontol 1996; 23(10): 960–970.
87 Quirynen M, Zhao H, Soers C et al. The impact of periodontal therapy and the adjunctive effect of antiseptics on breath odour-related outcome variables: a double-blind randomized study. J Periodontol 2005; 76(5): 705–712.
88 Delanghe G, Ghyselen J, Bollen C et al. An inventory of patients’ response to treatment at a multidisciplinary breath odor clinic. Quint Int 1999; 70(3): 307–310.
89 Rosenberg M, Gelernter I, Barki M et al. Day-long reduction of oral malodour by a two- phase oil: water mouthrinse as compared to chlorhexidine and placebo rinses. J Periodontol 1992; 63(1): 39–43.
90 Pitts G, Brogdon C, Hu L et al. Mechanism of action of an antiseptic, antiodor mouthwash. J Dent Res 1983; 62(6): 738–742.
91 Frascella J, Gilbert R, Fernandez P. Door reduction potential of a chlorine dioxide mouthrinse. J Clin Dent 1998; 9(1): 39–42.
92 Raven S, Matheson J, Huntington E et al. The efficacy of a combined zinc and triclosan system in the prevention of oral malodour. In: van Steenberghe D, Rosenberg M, editors. Bad breath: a multidisciplinary approach. Leuven: Leuven University Press, 1996: 241–254.
93 Suarez FL, Furne JK, Springfield J et al. Morning breath odour: influence of treatments on sulphur-gases. J Dent Res 2000; 79(10): 1773–1777.
94 Navada R, Kumari H, Le S et al. Oral malodour reduction from a zinc-containing toothpaste. J Clin Dent 2008; 19(2): 69–73.
95 Feng X, Chen X, Cheng R et al. Breath malodour reduction with use of a stannous containing sodium fluoride dentifrice: a meta-analysis of four randomized and controlled clinical trials. Am J Dent 2010; 23(Spec No B): 27B–31B.
96 Sharma NC, Galustians HJ, Qaqish J et al. Clinical effectiveness of a dentifrice containing triclosan and a copolymer for controlling breath odour. Am J Dent 2007;
20(2): 79–82.
97 Fedorowicz Z, Aljufairi H, Nasser M et al. Mouthrinses for the treatment of halitosis.
Cochrane Database Syst Rev 2008; (4): CD006701.
98 Young A, Jonski G, Ro¨lla G et al. Effects of metal salts on the oral production of volatile sulphur containing compounds (VSC). J Clin Periodontol 2001; 28(8):
776–781.
99 Young A, Jonski G, Ro¨lla G. Inhibition of orally produced volatile sulphur compounds by zinc, chlorhexidine or cetylpyridinium chloride—effect of concentration. Eur J Oral Sci 2003; 111(5): 400–404.
100 Sterer N, Rubinstein Y. Effect of various natural medicinals on salivary protein putrefaction and malodour production. Quint Int 2006; 37(8): 653–658.
101 Grandis JR, Johnson JT, Vickers RM et al. The efficacy of perioperative antibiotic therapy on recovery following tonsillectomy in adults: randomized double-blind placebo-controlled trial. Otolaryngol Head Neck Surg 1992; 106(2): 137–142.
102 Bunzen DL, Campos A, Lea˜o FS et al. Efficacy of functional endoscopic sinus surgery for symptoms in chronic rhinosinusitis with or without polyposis. Braz J Otorhinolaryngol 2006; 72(2): 242–246.
103 Dal Rio AC, Passos CA, Nicola JH et al. CO2laser cryptolysis by coagulation for the treatment of halitosis. Photomed Laser Surg 2006; 24(5): 630–636.
104 Shortt P, Wilson R, Erskine I. Tendinitis: the Achilles heel of quinolones! Emerg Med J 2006; 23(12): e63.
105 Labenz J, Morgner-Miehlke A. An update on the available treatments for non-erosive reflux disease. Expert Opin Pharmacother 2006; 7(1): 47–56.
106 Bytzer P, Dahlerup JF, Eriksen JR et al. Diagnosis and treatment of Helicobacter pylori infection. Dan Med Bull 2011; 58(4): C4271.
107 Malaguarnera M, Restuccia S, Motta M et al. Interferon, cortisone, and antivirals in the treatment of chronic viral hepatitis: a review of 30 years of therapy.
Pharmacotherapy 1997; 17(5): 998–1005.
108 Burton JP, Chilcott CN, Moore CJ et al. A preliminary study of the effect of probiotic Streptococcus salivarius K12on oral malodour parameters. J Appl Microbiol 2006;
100(4): 754–764.
109 Iwamoto T, Suzuki N, Tanabe K et al. Effects of probiotic Lactobacillus salivarius WB21on halitosis and oral health: an open-label pilot trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110(2): 201–208.
110 Kang MS, Kim BG, Chung J et al. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol 2006; 33(3): 226–232.
111 Henker J, Schuster F, Nissler K. Successful treatment of gut-caused halitosis with a suspension of living non-pathogenic Escherichia coli bacteria—a case report. Eur J Pediatr 2001; 160(10): 592–594.
112 Nagel D, Lutz C, Filippi A. Halitophobia—an under-recognized clinical picture.
Schweiz Monatsschr Zahnmed 2006; 116(1): 57–64.
113 Malasi TH, El-Hilu SM, Mirza IA et al. Olfactory delusional syndrome with various aetiologies. Br J Psychiatry 1990; 156: 256–260.
114 Bohn P. Imagined halitosis: a social phobia symptom? J Calif Dent Assoc 1997; 25(2):
161–164.
115 Eli I, Koriat H, Baht R et al. Self-perception of breath odor: role of body image and psychopathologic traits. Percept Mot Skills 2000; 91(3 Pt 2): 1993–2001.
116 Lochner C, Stein DJ. Olfactory reference syndrome: diagnostic criteria and differential diagnosis. J Postgrad Med 2003; 49(4): 328–331.
117 Suzuki N, Yoneda M, Naito T et al. Relationship between halitosis and psychologic status. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008 Oct;106(4): 542–547.
118 Adams KH, Hansen ES, Pinborg LH et al. Patients with obsessive/compulsive disorder have increased 5-HT2Areceptor binding in caudate nuclei. Int J Neuropsycho- pharmacol 2005; 8(3): 391–401.
119 Uher R, Farmer A, Henigsberg N et al. Adverse reactions to antidepressants. Br J Psychiatry 2009; 195(3): 202–210.
120 Persson S, Edlund MB, Claesson R et al. The formation of hydrogen sulphide and methylmercaptan by oral bacteria. Oral Microbiol Immunol 1990; 5(4): 195–201.
121 Claus D, Geypens B, Rutgeerts P et al. Where gastroenterology and periodontology meet: determination of oral volatile organic compounds using closed-loop trapping and high-resolution gas chromatography-ion trap detection. In: van Steenberghe D, Rosenberg M, editors. Bad breath: a multidisciplinary approach. Leuven: Leuven University Press, 1996: 15–28.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivative Works 3.0 Unported License. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-nd/3.0
